Calithera Biosciences, Inc. (CALA)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Dec 27, 2024, 4:00 PM EST
Calithera Biosciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
487.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 21.77M |
| Jun An Kang Group | 4.47M |
| BioStem Technologies | 210.49M |
Calithera Biosciences News
- 1 year ago - Calithera Biosciences Announces Update on Complete Liquidation and Dissolution - GlobeNewsWire
- 2 years ago - Calithera Biosciences Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 2 years ago - Calithera Biosciences, Inc. (CALA) Q3 2022 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update - GlobeNewsWire
- 2 years ago - Calithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 - GlobeNewsWire
- 2 years ago - Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate - Market Watch
- 2 years ago - Calithera Receives FDA Fast Track Designation for Sapanisertib for the Treatment of NRF2-mutated Squamous Lung Cancer - GlobeNewsWire
- 2 years ago - Calithera to Present at the H.C. Wainwright 24th Annual Global Investment Conference - GlobeNewsWire